Breast cancer survival rates continue to improve, with over 4 million survivors in the United States alone. However, the journey beyond diagnosis presents significant challenges to quality of life, particularly for women with hormone receptor-positive (HR+) cancers who require long-term endocrine therapy. Sexual dysfunction affects up to 93% of women on aromatase inhibitor therapy, profoundly impacting intimate relationships and marital satisfaction. This article examines the biological mechanisms underlying these challenges, the impact on relationships and marriages, and evidence-based treatment strategies specifically tailored for HR+ breast cancer survivors seeking to reclaim their sexual health and intimate connections.

We tend to think of estrogen solely as a reproductive hormone—the thing that gives us periods and helps us make babies. But estrogen is actually a powerhouse metabolic regulator. It dictates how your body burns energy, where it stores fat, and how it responds to insulin. During the transition into menopause, your ovaries stop producing consistent levels of estradiol. This drop does far more than trigger hot flashes; it flips a switch in your metabolic engine.

As a physician, I've dedicated my career to bridging two worlds of medical knowledge—I'm trained by both the Institute for Functional Medicine (IFM) and the Menopause Society. This dual perspective lets me offer a blended, cost-effective approach that prioritizes both your safety and your long-term vitality. My goal is simple: help you feel and function better by addressing the root causes of your symptoms while using clinically proven treatments.

For many women in their 40s, the "midlife shift" begins with a specific brand of exhaustion—the kind that coffee can't fix and a full night's sleep barely touches. Usually, the first suspect is perimenopause. And while declining estrogen is often to blame, there is a "Great Mimicker" lurking in the background for millions of women: Hashimoto's Thyroiditis.

The relationship between estradiol (the primary form of estrogen in the female body) and cholesterol metabolism is well-established in the medical literature, yet it remains one of the most overlooked factors in women's cardiovascular health. Research published in peer-reviewed journals consistently demonstrates that declining estrogen levels fundamentally alter how the body processes cholesterol. Understanding this connection can empower you to have more informed conversations with your healthcare provider and advocate for your cardiovascular health.

Peptides, while recommended in some situations, are not a replacement for foundational health. They are not a shortcut, not a magic solution, and certainly not appropriate for everyone. In my practice, I only consider peptides as a potential addition after we've optimized hormonal health, addressed nutritional deficiencies, regulated nervous system strain, and established consistent lifestyle habits including strength training, quality sleep, and stress reduction.

What feels like breakdown during perimenopause is actually your body's desperate attempt to protect you from a lifetime of chronic stress it can no longer sustain. Learn why your overwhelm has real physiological causes—and what you can do about it.

The anxiety, rage, and depression that arrive in perimenopause are not signs of a new psychiatric disorder—they are predictable neurobiological responses to hormonal change. Understanding the science is the first step toward effective treatment.

On November 10, 2025, the FDA announced the removal of black box warnings from menopausal hormone therapy products—a decision that FDA Commissioner Dr. Marty Makary called "one of the greatest mistakes in modern medicine" to finally correct[1]. As a physician who specializes in perimenopause and menopause care in Ohio, I've spent years watching qualified women be denied treatment because of outdated fears. This announcement should be cause for celebration. And it is, but with important caveats that every woman and clinician needs to understand.

On the surface, combined oral contraceptives (COCs) and menopause hormone therapy both contain estrogen and a progesterone-like hormone. Both can reduce hot flashes, heavy bleeding, and night sweats. Both support bone health in the short term. But beneath that surface similarity lies a crucial difference in design and purpose.​

Perimenopause can be a significant transition in a woman’s life—one that is widely misunderstood and often neglected in conventional healthcare. If you’re experiencing shifts in mood, energy, cognition, or bodily comfort in your 30s, 40s, or early 50s, you are not alone. This comprehensive guide will empower you to understand perimenopause, recognize its earliest and most surprising signs, and know when to seek help. At Bonza Health, our holistic approach centers your unique experience—because perimenopause is not “one size fits all.”

A groundbreaking 2025 randomized controlled trial, recently published in the Journal of the American Nutrition Association, looked specifically at the effects of creatine on brain metabolism, mood, reaction time, and lipid health in midlife women. The results were remarkable: even low doses of creatine hydrochloride led to measurable improvements in brain energy, focus, and emotional balance—with no identified adverse effects.

The 2002 Women’s Health Initiative (WHI) study didn’t just shift the prescribing of menopause hormone therapy: it reshaped the cultural and clinical landscape of menopause care. Fear replaced discussion, and caution became policy. An entire generation of women suffered—not because of data, but because of its misinterpretation.

Testosterone isn’t just a “male hormone.” It’s an essential part of every woman’s hormonal orchestra—powerfully influencing libido, mood, cognition, and energy. As a Menopause Society Certified Physician, I often see women who have optimized their estrogen and progesterone therapy yet still feel their spark is missing. That missing piece? Often testosterone.

As estrogen and progesterone fluctuate and ultimately decline during perimenopause, women often notice unexpected symptoms like bloating, irregular bowel habits, or even food intolerances. Behind these digestive issues is a crucial player: the gut microbiome, a complex ecosystem of trillions of microbes that deeply influences hormone regulation, immune function, and even mental health.

During perimenopause, many women experience fluctuating estrogen and progesterone levels that can have profound effects—not only on physical health, but on the brain and mood. For neurodivergent women, including those with ADHD or autism spectrum conditions, these changes may be especially destabilizing.

Perimenopause is a complex and widely misunderstood transition period in a woman's life, yet it represents a critical window for preventive health and symptom management. Despite affecting millions globally, many women do not recognize their symptoms as perimenopausal, and physicians often lack adequate training to diagnose and support this stage. Women frequently experience perplexing symptoms—irregular periods, mood shifts, fatigue, sleep disruptions—long before the final menstrual period.

Perimenopause and menopause are profound physiological transitions for women: periods where unpredictable hormone shifts can impact every tissue, especially the musculoskeletal system. Many women, including those seen daily at Bonza Health, struggle with new-onset joint pain, stiffness, and even disabling arthritis.

Cortisol is the hidden hormone that often gets overlooked in perimenopause, yet it has the power to disrupt sleep, mood, cognition, and metabolism—while also offering opportunities for holistic, personalized wellness strategies. This comprehensive blog explores the science, symptom patterns, and action plans for navigating cortisol challenges during perimenopause, featuring visuals and practical protocols.

A recent wave of studies and updated guidelines now recommend considering menopausal hormone therapy (MHT)—rather than antidepressants—as the preferred initial treatment for psychological symptoms in perimenopausal women who do not have a diagnosis of major depressive disorder.